Nuveen Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $11.5M | Buy |
428,858
+158,452
| +59% | +$4.23M | ﹤0.01% | 1528 |
|
|
2024
Q3 | $7.22M | Buy |
270,406
+27,308
| +11% | +$729K | ﹤0.01% | 1803 |
|
|
2024
Q2 | $4.38M | Sell |
243,098
-94,906
| -28% | -$1.71M | ﹤0.01% | 2023 |
|
|
2024
Q1 | $6.17M | Buy |
338,004
+184,712
| +120% | +$3.37M | ﹤0.01% | 1866 |
|
|
2023
Q4 | $1.68M | Buy |
153,292
+806
| +0.5% | +$8.82K | ﹤0.01% | 2496 |
|
|
2023
Q3 | $874K | Sell |
152,486
-1,016
| -0.7% | -$5.82K | ﹤0.01% | 2628 |
|
|
2023
Q2 | $1.19M | Buy |
153,502
+55,678
| +57% | +$432K | ﹤0.01% | 2579 |
|
|
2023
Q1 | $653K | Sell |
97,824
-8,878
| -8% | -$59.3K | ﹤0.01% | 2741 |
|
|
2022
Q4 | $954K | Sell |
106,702
-4,907
| -4% | -$43.9K | ﹤0.01% | 2699 |
|
|
2022
Q3 | $1.1M | Sell |
111,609
-2,728
| -2% | -$26.9K | ﹤0.01% | 2713 |
|
|
2022
Q2 | $910K | Buy |
114,337
+4,222
| +4% | +$33.6K | ﹤0.01% | 2827 |
|
|
2022
Q1 | $1.15M | Buy |
110,115
+16,765
| +18% | +$175K | ﹤0.01% | 2766 |
|
|
2021
Q4 | $1.8M | Buy |
93,350
+64,387
| +222% | +$1.24M | ﹤0.01% | 2616 |
|
|
2021
Q3 | $501K | Sell |
28,963
-17,877
| -38% | -$309K | ﹤0.01% | 3167 |
|
|
2021
Q2 | $999K | Buy |
+46,840
| New | +$999K | ﹤0.01% | 3005 |
|